Zoetis ZTS Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $9.51B+2.6% | $9.45B+2.0% | $9.38B+2.4% | $9.36B+5.0% | $9.26B+6.1% | ||
| $2.69B-0.3% | $2.66B-2.1% | $2.66B-3.0% | $2.68B-0.1% | $2.69B+3.0% | ||
| $6.82B+3.9% | $6.78B+3.8% | $6.72B+4.8% | $6.69B+7.2% | $6.57B+7.4% | ||
| 71.8%+0.8pp | 71.8%+1.2pp | 71.7%+1.6pp | 71.4%+1.5pp | 70.9%+0.9pp | ||
| $721M+5.1% | $703M+2.5% | $690M+2.4% | $687M+4.2% | $686M+8.2% | ||
| $2.4B+2.5% | $2.39B+3.1% | $2.4B+6.1% | $2.38B+7.3% | $2.35B+6.9% | ||
| $230M+4.1% | $222M-1.3% | $216M-7.3% | $215M-8.5% | $221M-5.6% | ||
| $38M+46.2% | $33M+73.7% | $44M+529% | $47M+413% | $26M-77.2% | ||
| $3.31B+4.7% | $3.32B+6.1% | $3.29B+8.0% | $3.28B+13.4% | $3.16B+5.8% | ||
| $665M+0.8% | $679M+6.6% | $672M+9.6% | $688M+24.6% | $660M+10.4% | ||
| $2.64B+6.2% | $2.64B+6.4% | $2.62B+7.9% | $2.58B+10.2% | $2.49B+4.1% | ||
| 27.8%+0.9pp | 28%+1.1pp | 28%+1.4pp | 27.6%+1.3pp | 26.9%-0.5pp | ||
| $6.03+9.6% | $5.95+8.8% | $5.87+10.3% | $5.74+12.3% | $5.50+6.0% | ||
| $4.03B+4.0% | $4.03B+4.6% | $4B+5.7% | $3.98B+9.6% | $3.87B+4.1% | ||
| 42.3%+0.6pp | 42.7%+1.0pp | 42.7%+1.3pp | 42.5%+1.8pp | 41.8%-0.8pp | ||
| $3.54B+4.7% | $3.55B+5.6% | $3.51B+6.9% | $3.5B+11.7% | $3.38B+5.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Zoetis's revenue?
- Zoetis (ZTS) generated $9.5B in revenue over the trailing twelve months, up 2.6% year over year.
- Is Zoetis profitable?
- Zoetis reported $2.6B in net income over the trailing twelve months, a 27.8% net margin.
- What is Zoetis's earnings per share?
- Zoetis's diluted EPS over the trailing twelve months is $6.03.
- Where does Zoetis's income statement data come from?
- Every line is extracted from Zoetis's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
